Translocator protein: Difference between revisions
CSV import |
CSV import |
||
| Line 30: | Line 30: | ||
__NOINDEX__ | __NOINDEX__ | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 03:02, 18 March 2025
Translocator protein (TSPO), previously known as the peripheral benzodiazepine receptor (PBR), is a protein located primarily within the outer mitochondrial membrane of steroid-synthesizing tissues, including the brain. TSPO is implicated in a variety of biological processes, such as cholesterol transport and steroid hormone synthesis, apoptosis, cell proliferation, and immune response.
Structure[edit]
The TSPO protein is a five transmembrane domain protein. The exact structure of TSPO is still under investigation, but it is known to form a complex with other proteins, such as the voltage-dependent anion channel (VDAC) and the adenine nucleotide transporter (ANT).
Function[edit]
TSPO has been implicated in a variety of biological processes. It is involved in the transport of cholesterol into mitochondria, a crucial step in the synthesis of steroid hormones. TSPO also plays a role in cell proliferation, apoptosis, and immune response. In the brain, TSPO is upregulated in response to injury or inflammation, making it a potential target for imaging and therapeutic interventions.
Clinical significance[edit]
TSPO has been studied for its potential role in a variety of diseases, including neurodegenerative disorders, psychiatric disorders, and cancer. TSPO ligands have been developed for use in positron emission tomography (PET) imaging to visualize areas of inflammation or injury in the brain. Additionally, TSPO-targeted therapies are being explored for their potential use in treating a variety of conditions, including anxiety disorders, neurodegenerative diseases, and cancer.
See also[edit]
References[edit]
<references />
External links[edit]
- TSPO at the US National Library of Medicine Medical Subject Headings (MeSH)
